CARDIAC TOXICITY
Clinical trials for CARDIAC TOXICITY explained in plain language.
Never miss a new study
Get alerted when new CARDIAC TOXICITY trials appear
Sign up with your email to follow new studies for CARDIAC TOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart-Saving statins may keep breast cancer therapy on track
Disease control Recruiting nowThis study tests whether adding statins can prevent heart problems caused by HER2-targeted therapy in people with early-stage breast cancer. About 60 women will take statins alongside their cancer treatment to see if it reduces treatment delays or early stops. The goal is to keep…
Matched conditions: CARDIAC TOXICITY
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
Heart meds after cancer: can you finally stop?
Disease control Recruiting nowThis study looks at whether cancer survivors who had temporary heart damage from chemotherapy can safely stop taking heart failure medications once their heart function has recovered. About 335 adults who finished cancer treatment at least 6 months ago and are currently on heart …
Matched conditions: CARDIAC TOXICITY
Phase: PHASE4 • Sponsor: Dinesh Thavendiranathan • Aim: Disease control
Last updated May 26, 2026 04:29 UTC